Molgramostim shows promise in rare lung disease treatment
LANGHORNE, Pa. - Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases with a ...
XBI: Diverse Holding Amid Strong Catalysts, Buy
Invest in SPDR S&P Biotech ETF (XBI) for long-term growth potential and diverse, equal-weighted portfolio in the biotech ...